Propranolol Safety Profile in Children

被引：9

作者：

El-Shabrawi, Mortada ^{[1
]}

Hassanin, Fetouh ^{[2
]}

机构：

[1] Cairo Univ, Fac Med, Giza, Egypt

[2] Misr Int Univ, Cairo, Egypt

来源：

CURRENT DRUG SAFETY | 2011年 / 6卷 / 04期

关键词：

Children; hemangioma; portal hypertension; propranolol; safety; side effects;

D O I：

10.2174/157488611798280889

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Data regarding the use of propranolol in pediatrics are limited despite its widespread use in adults. Since 1984, Propranolol has been used for the prevention of portal hypertensive hemorrhage in pediatric patients. Recently it has been also used for the managemnet of hemangiomas in addition to other indications. The purpose of this review is to evaluate safety and efficacy of propranolol use in the pediatric population, highlighting the most important reported side effects, warnings and precautions.

引用

页码：259 / 266

页数：8

共 41 条

[1]

American Diabetes Association, 2002, DIABETES CARE S1, V25, pS33, DOI [10.2337/diacare.25.2007.S33, DOI 10.2337/DIACARE.25.2007.S33, 10.2337/diacare.25.2007.s33]

[2]

[Anonymous], 2008, PROPR HYDR OR SOL PR

[3]

Ayerst Laboratories Inc, 2002, IND PROPR HYDR TABL

[4] Propranolol for the Treatment of Severe Hemangiomas of Infancy: Results From a Series of 28 Patients [J].